| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Renaissance Technologies Jim Simons (founder) | 545K | $20.37M | NEW |
| D.E. Shaw David Shaw | 64K | $2.38M | NEW |
| Hussman Investment Trust John Hussman | 42K | $2.32M | – |
| Citadel Ken Griffin | 56K | $2.11M | NEW |
| Point72 Steve Cohen | 34K | $1.26M | NEW |
Phibro Animal Health Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of a wide range of animal health and mineral nutrition solutions. Primarily, the company serves the livestock and poultry sectors by providing medications and vaccines that enhance the health and productivity of animals. Phibro's extensive product portfolio includes antimicrobials, vaccines, mineral premixes, and specialty products developed to support the animal agriculture industry. The company plays a significant role in improving animal welfare as well as animal-derived food safety, thus contributing directly to the agricultural supply chain. Established in 1946 and headquartered in Teaneck, New Jersey, Phibro operates globally, catering to the needs of veterinarians, farmers, and feed producers across diverse markets. Its products are pivotal in addressing challenges such as outbreaks of diseases among livestock, thereby helping to ensure the profitability and sustainability of animal farming operations worldwide.
Earnings calendar coming soon. Subscribe to get notified when PAHC reports next.
Get earnings alerts →